UK's AstraZeneca begins human trial of Covid-19 treatment using monoclonal antibodies - b e news

Post Top Ad

BioTopic

UK's AstraZeneca begins human trial of Covid-19 treatment using monoclonal antibodies

Share This
UK-based pharmaceutical company AstraZeneca announced on Tuesday that it had begun the human trial of a new treatment for Covid-19 using a combination of two monoclonal antibodies.

No comments:

Post a Comment

Post Bottom Ad

Pages